Connecting Genomic Alterations to Cancer Biology with Proteomics

Detailed Evaluation Results for Connecting Genomic Alterations to Cancer Biology with Proteomics

17 of the 36 faculty that attended completed evaluations.

The workshop was led by Henry Rodriguez from the National Cancer Institute on Cancer Research.

Faculty responded in the surveys that the session lived up to their expectations and that the information given at the workshop increased their knowledge of current science. They learned about "the vision of NIH moving towards correlating protein with genome data and new technology and websites with data", "the need for administrators to look broadly, take initiative and operate on a long-horizon basis; the importance of administrators who do these things", and "the tools available for cancer research." One participant mentioned that they are "about to start a small-scale phosphoproteomics project, and we'll be doing that a little differently based upon the outcomes Henry Rodriguez reported from his own phosphoproteomics work."

Overall, participants said that this was "very exciting stuff. Happy to get a look at the very newest and most exciting things happening at NCI and it's great to think about how that is impacting the present and future of research on a national level " and this was "great, too bad more people at FIU did not attend."

Questions & Responses

The presentation lived up to my expectations.
N=18 Mean=4.94 SD=0.24 Range= 1 (strongly disagree)- 5 (strongly agree)

This session increased my knowledge of current science.
N=18 Mean=5.00 SD=0 Range= 1 (strongly disagree)- 5 (strongly agree)

The content of this presentation was applicable to my area of research.
N=16 Mean=4.19 SD=1.38 Range= 1 (strongly disagree)- 5 (strongly agree)

I am glad I took the time to participate in this presentation.
N=15 Mean=5.00 SD=0 Range= 1 (strongly disagree)- 5 (strongly agree)

Questions & Answers:

Please give a specific example of at least one thing you learned and will definitely take from the Rodriguez workshop to use in your research and work.

  • The vision of NIH moving towards correlating protein with genome data - and new technology and websites with data.
  • I'm about to start a small-scale phosphoproteomics project, and we'll be doing that a little differently based upon the outcomes Henry Rodriguez reported from his own phosphoproteomics work.
  • The need for administrators to look broadly, take initiative and operate on a long-horizon basis; the importance of administrators who do these things.
  • Antibody characterization program.
  • Data sharing.
  • I learned the most recently developed new research and technology assay on cancer research.
  • The tools available for cancer research; as well as new data.
  • The availability of public databases, data files, assays and monoclonal antibodies.
  • I am interested in the subject, but it is not applicable to my work - I am not engaged in research.
  • Importance of protein and phenotype.
  • Availability of proteomic database related to cancer.

Is there anything that could have been improved about this workshop?

  • Construction of talk was a little challenging in some areas. I would benefit from hearing (earlier in the presentation) about what practical questions/applications/examples does the topic relate to? This science is on such a large intensive scale that a few more instances of framing would help me to fully appreciate the ramifications.
  • Food options.
  • Timing (started about 30 minutes after scheduled time).

General Comments about the overall workshop?

  • Excellent content & delivery
  • Very exciting stuff. Very happy to get a look at the very newest and most exciting things happening at NCI and it's great to think about how that is impacting the present and future of research on a national level (as well as the level of specifics for individual research labs).
  • Excellent.
  • Well done!
  • Very informative about new development In cancer research field.
  • Excellent.
  • Great. Too bad more people at FIU did not attend.
  • Excellent.